← Eichor
Study identifier: NCT05937620 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Condition: Ovarian Epithelial Cancer  ·  Sponsor: Fundacion Clinic per a la Recerca Biomédica

PhaseNA
Planned participants62
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Laura Burunat, Graduate  ·  0034 932275400  ·  burunat@recerca.clinic.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Laura BurunatBarcelona, Catalonia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05937620